Paper77475
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
Salmon SE and 5 others. N Engl J Med, 1978. Cited by 1,068 papers, by iCite.
Cite this record
ConductScience Library. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. Papers, record 77475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/77475
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Clone Cells | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Bleomycin | |
| Carmustine | |
| Doxorubicin | |
| Drug Resistance | |
| Female | |
| Humans | |
| Melphalan | |
| Methotrexate | |
| Multiple Myeloma | |
| Ovarian Neoplasms | |
| Prognosis | |
| Prospective Studies | |
| Retrospective Studies | |
| Vinblastine |
Source PubMed
Cited by242
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,068 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41695491 | From 2D cultures to 3D systems: evolving cancer models at the interface of functional precision medicine and theranostics. | Theranostics | 2026 | https://conductscience.org/library/papers/41695491 | PubMed |
| 40964661 | Advances and challenges in human 3D solid tumor models. | Adv Funct Mater | 2025 | https://conductscience.org/library/papers/40964661 | PubMed |
| 40873434 | Bridging the gap: the role of 3D cell cultures in mimicking tumor microenvironment for enhanced drug testing accuracy. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40873434 | PubMed |
| 39861111 | Pharmaceutical Humanities and Narrative Pharmacy: An Emerging New Concept in Pharmacy. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/39861111 | PubMed |
| 38040674 | Standardized assays to monitor drug sensitivity in hematologic cancers. | Cell Death Discov | 2023 | https://conductscience.org/library/papers/38040674 | PubMed |
| 37852342 | From shape-shifting embryonic cells to oncology: The fascinating history of epithelial mesenchymal transition. | Semin Cancer Biol | 2023 | https://conductscience.org/library/papers/37852342 | PubMed |
| 36358633 | Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358633 | PubMed |
| 35625628 | Automated-Mechanical Procedure Compared to Gentle Enzymatic Tissue Dissociation in Cell Function Studies. | Biomolecules | 2022 | https://conductscience.org/library/papers/35625628 | PubMed |
| 34703845 | Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/34703845 | PubMed |
| 34646385 | Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept. | Theranostics | 2021 | https://conductscience.org/library/papers/34646385 | PubMed |
| 34222745 | Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics. | Annu Rev Cancer Biol | 2021 | https://conductscience.org/library/papers/34222745 | PubMed |
| 31384612 | Clinical value of an adenosine triphosphate-based chemotherapy response assay in resectable stage III colorectal cancer. | Ann Surg Treat Res | 2019 | https://conductscience.org/library/papers/31384612 | PubMed |
| 29510509 | Miniaturization of the Clonogenic Assay Using Confluence Measurement. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29510509 | PubMed |
| 29285367 | Clinical study on collagen gel droplet-embedded culture drug sensitivity test for multidrug combination chemotherapy and super selective intra-arterial infusion chemoradiotherapy in oral squamous cell carcinoma. | Mol Clin Oncol | 2017 | https://conductscience.org/library/papers/29285367 | PubMed |
| 28855997 | Collagen gel droplet-embedded culture drug sensitivity testing in hard palate cancer-predicted antitumor efficacy of cetuximab: A case report. | Mol Clin Oncol | 2017 | https://conductscience.org/library/papers/28855997 | PubMed |
| 28105171 | Collagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracil. | Oncol Lett | 2016 | https://conductscience.org/library/papers/28105171 | PubMed |
| 27239797 | lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal. | Nat Struct Mol Biol | 2016 | https://conductscience.org/library/papers/27239797 | PubMed |
| 27218886 | Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement. | Pharmacol Ther | 2016 | https://conductscience.org/library/papers/27218886 | PubMed |
| 27145761 | Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients. | Curr Pharm Des | 2016 | https://conductscience.org/library/papers/27145761 | PubMed |
| 26549537 | 3D matrix-based cell cultures: Automated analysis of tumor cell survival and proliferation. | Int J Oncol | 2016 | https://conductscience.org/library/papers/26549537 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/77475
GET https://conductscience.org/api/papers/v1/77475/cited_by?page=2